{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:42:54Z","timestamp":1788536574170,"version":"build-2803163510"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2021-0263_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the applicability of a standardized multidisciplinary protocol for managing placenta accreta spectrum (PAS) disorders and its impact on the outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2021-0263_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared patients with PAS manage by a standardized multidisciplinary protocol (T2) to historic controls managed on a case-by-case basis by individual physicians between (T1). The primary outcome is composite maternal morbidity. Secondary outcomes were the rates of surgical complications, estimated blood loss, number of blood products transfused, intensive care unit admissions, ventilator use, and birth weight. Multivariate logistic analysis was used to identify independent predictors of composite maternal morbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2021-0263_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During T1 and T2, we managed 39 and 36 patients with confirmed PAS, respectively. During T2, the protocol could be implemented in 21 cases (58%). Compared to T1, patients managed during T2 had 70% less composite maternal morbidity (95% CI: 0.11\u20130.82) and lower blood loss (median, 2,000 vs. 1,100\u00a0mL, p=0.008). Also, they were 68% less likely to require transfusion of blood products (95% CI: 0.12\u20130.81; p=0.01), including fewer units of packed red blood cells (median, 2 vs. 0, p=0.02). Management following the protocol was the only independent factor associated with lower composite maternal morbidity (OR: 0.22; 95% CI: 0.05\u20130.95; p=0.04). Selected maternal and neonatal outcomes were not different among 12 and 15 patients with suspected but unconfirmed PAS disorders managed during T1 and T2, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2021-0263_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Most patients can be managed under a standardized multidisciplinary protocol for PAS disorders, leading to improved outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2021-0263","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T23:23:37Z","timestamp":1639524217000},"page":"286-293","source":"Crossref","is-referenced-by-count":8,"title":["Improved management of placenta accreta spectrum disorders: experience from a single institution"],"prefix":"10.1515","volume":"50","author":[{"given":"Kendra","family":"Sylvester-Armstrong","sequence":"first","affiliation":[{"name":"University of Florida College of Medicine , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-5419","authenticated-orcid":false,"given":"Callie","family":"Reeder","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Patrick","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet R.","family":"Genc","sequence":"additional","affiliation":[{"name":"University of Florida College of Medicine , Gainesville , FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"2023040100552174320_j_jpm-2021-0263_ref_001","doi-asserted-by":"crossref","unstructured":"Silver, RM, Branch, DW. Placenta accreta spectrum. N Engl J Med 2018;378:1529\u201336. https:\/\/doi.org\/10.1056\/nejmcp1709324.","DOI":"10.1056\/NEJMcp1709324"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_002","doi-asserted-by":"crossref","unstructured":"Duzyj, CM, Cooper, A, Mhatre, M, Han, CS, Paidas, MJ, Illuzzi, JL, et al.. Placenta accreta: a spectrum of predictable risk, diagnosis, and morbidity. Am J Perinatol 2019;36:1031\u20138. https:\/\/doi.org\/10.1055\/s-0038-1676111.","DOI":"10.1055\/s-0038-1676111"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_003","doi-asserted-by":"crossref","unstructured":"Yasin, N, Slade, L, Atkinson, E, Kennedy-Andrews, S, Scroggs, S, Grivell, R. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: a ten-year experience. Aust N Z J Obstet Gynaecol 2019;59:550\u20134. https:\/\/doi.org\/10.1111\/ajo.12932.","DOI":"10.1111\/ajo.12932"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_004","doi-asserted-by":"crossref","unstructured":"Fox, KA, Shamshirsaz, AA, Carusi, D, Secord, AA, Lee, P, Turan, OM, et al.. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol 2015;213:755\u201360. https:\/\/doi.org\/10.1016\/j.ajog.2015.04.034.","DOI":"10.1016\/j.ajog.2015.04.034"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_005","doi-asserted-by":"crossref","unstructured":"Sentilhes, L, Kayem, G, Chandraharan, E, Palacios-Jaraquemada, J, Jauniaux, E, Diagnosis, FPA, et al.. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet 2018;140:291\u20138. https:\/\/doi.org\/10.1002\/ijgo.12410.","DOI":"10.1002\/ijgo.12410"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_006","doi-asserted-by":"crossref","unstructured":"Sichitiu, J, El-Tani, Z, Mathevet, P, Desseauve, D. Conservative surgical management of placenta accreta spectrum: a pragmatic approach. J Invest Surg 2019;20:1\u20139. https:\/\/doi.org\/10.1080\/08941939.2019.1623956.","DOI":"10.1080\/08941939.2019.1623956"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_007","doi-asserted-by":"crossref","unstructured":"Collins, SL, Alemdar, B, van Beekhuizen, HJ, Bertholdt, C, Braun, T, Calda, P, et al.. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol 2019;220:511\u201326. https:\/\/doi.org\/10.1016\/j.ajog.2019.02.054.","DOI":"10.1016\/j.ajog.2019.02.054"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_008","doi-asserted-by":"crossref","unstructured":"Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, Cahill, AG, Beigi, R, Heine, RP, Silver, RM, et al.. Placenta accreta spectrum. Am J Obstet Gynecol 2018;219:B2\u201316. https:\/\/doi.org\/10.1016\/j.ajog.2018.09.042.","DOI":"10.1016\/j.ajog.2018.09.042"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_009","doi-asserted-by":"crossref","unstructured":"Clark, EA, Silver, RM. Long-term maternal morbidity associated with repeat cesarean delivery. Am J Obstet Gynecol 2011;205:S2\u201310. https:\/\/doi.org\/10.1016\/j.ajog.2011.09.028.","DOI":"10.1016\/j.ajog.2011.09.028"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_010","doi-asserted-by":"crossref","unstructured":"Mulla, BM, Weatherford, R, Redhunt, AM, Modest, AM, Hacker, MR, Hecht, JL, et al.. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa. Arch Gynecol Obstet 2019;300:1601\u20136. https:\/\/doi.org\/10.1007\/s00404-019-05338-y.","DOI":"10.1007\/s00404-019-05338-y"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_011","doi-asserted-by":"crossref","unstructured":"Shamshirsaz, AA, Fox, KA, Salmanian, B, Diaz-Arrastia, CR, Lee, W, Baker, BW, et al.. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015;212:218.e1\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2014.08.019.","DOI":"10.1016\/j.ajog.2014.08.019"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_012","doi-asserted-by":"crossref","unstructured":"Silver, RM, Landon, MB, Rouse, DJ, Leveno, KJ, Spong, CY, Thom, EA, et al.. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226\u201332. https:\/\/doi.org\/10.1097\/01.aog.0000219750.79480.84.","DOI":"10.1097\/01.AOG.0000219750.79480.84"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_013","doi-asserted-by":"crossref","unstructured":"Upson, K, Silver, RM, Greene, R, Lutomski, J, Holt, VL. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005\u20132010. J Matern Fetal Neonatal Med 2014;27:24\u20139. https:\/\/doi.org\/10.3109\/14767058.2013.799654.","DOI":"10.3109\/14767058.2013.799654"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_014","doi-asserted-by":"crossref","unstructured":"Fitzpatrick, KE, Sellers, S, Spark, P, Kurinczuk, JJ, Brocklehurst, P, Knight, M. The management and outcomes of placenta accreta, increta, and percreta in the U.K.: a population-based descriptive study. BJOG 2014;121:62\u201370. https:\/\/doi.org\/10.1111\/1471-0528.12405.","DOI":"10.1111\/1471-0528.12405"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_015","doi-asserted-by":"crossref","unstructured":"Bailit, JL, Grobman, WA, Rice, MM, Reddy, UM, Wapner, RJ, Varner, MW, et al.. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015;125:683\u20139. https:\/\/doi.org\/10.1097\/aog.0000000000000680.","DOI":"10.1097\/AOG.0000000000000680"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_016","doi-asserted-by":"crossref","unstructured":"American College of Obstetrics and Gynecology. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists, number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039\u201347.","DOI":"10.1097\/00006250-200610000-00046"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_017","doi-asserted-by":"crossref","unstructured":"Blanchette, H. The rising cesarean delivery rate in America: what are the consequences? Obstet Gynecol 2011;118:687\u201390. https:\/\/doi.org\/10.1097\/aog.0b013e318227b8d9.","DOI":"10.1097\/AOG.0b013e318227b8d9"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_018","doi-asserted-by":"crossref","unstructured":"Cheng, KK, Lee, MM. Rising incidence of morbidly adherent placenta and its association with previous caesarean section: a 15-year analysis in a tertiary hospital in Hong Kong. Hong Kong Med J 2015;21:511\u20137. https:\/\/doi.org\/10.12809\/hkmj154599.","DOI":"10.12809\/hkmj154599"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_019","doi-asserted-by":"crossref","unstructured":"Higgins, MF, Monteith, C, Foley, M, O\u2019Herlihy, C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol 2013;171:54\u20136. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.08.030.","DOI":"10.1016\/j.ejogrb.2013.08.030"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_020","doi-asserted-by":"crossref","unstructured":"Silver, RM, Fox, KA, Barton, JR, Abuhamad, AZ, Simhan, H, Huls, CK, et al.. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015;212:561\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2014.11.018.","DOI":"10.1016\/j.ajog.2014.11.018"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_021","doi-asserted-by":"crossref","unstructured":"Wang, M, Ballah, D, Wade, A, Taylor, AG, Rizzuto, G, Li, B, et al.. Uterine artery embolization following cesarean delivery but prior to hysterectomy in the management of patients with invasive placenta. J Vasc Intervent Radiol 2019;30:687\u201391. https:\/\/doi.org\/10.1016\/j.jvir.2018.12.007.","DOI":"10.1016\/j.jvir.2018.12.007"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_022","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Ayres-de-Campos, D, Langhoff-Roos, J, Fox, KA, Collins, S, Diagnosis, FPA, et al.. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019;146:20\u20134. https:\/\/doi.org\/10.1002\/ijgo.12761.","DOI":"10.1002\/ijgo.12761"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_023","doi-asserted-by":"crossref","unstructured":"Al-Khan, A, Gupta, V, Illsley, NP, Mannion, C, Koenig, C, Bogomol, A, et al.. Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci 2014;21:761\u201371. https:\/\/doi.org\/10.1177\/1933719113512528.","DOI":"10.1177\/1933719113512528"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_024","doi-asserted-by":"crossref","unstructured":"Smulian, JC, Pascual, AL, Hesham, H, Qureshey, E, Bijoy Thomas, M, Depuy, AM, et al.. Invasive placental disease: the impact of a multidisciplinary team approach to management. J Matern Fetal Neonatal Med 2017;30:1423\u20137. https:\/\/doi.org\/10.1080\/14767058.2016.1216099.","DOI":"10.1080\/14767058.2016.1216099"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_025","doi-asserted-by":"crossref","unstructured":"Eller, AG, Bennett, MA, Sharshiner, M, Masheter, C, Soisson, AP, Dodson, M, et al.. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011;117:331\u20137. https:\/\/doi.org\/10.1097\/aog.0b013e3182051db2.","DOI":"10.1097\/AOG.0b013e3182051db2"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_026","doi-asserted-by":"crossref","unstructured":"Sobol, JB, Gershengorn, HB, Wunsch, H, Li, G. The surgical Apgar score is strongly associated with intensive care unit admission after high-risk intraabdominal surgery. Anesth Analg 2013;117:438\u201346. https:\/\/doi.org\/10.1213\/ane.0b013e31829180b7.","DOI":"10.1213\/ANE.0b013e31829180b7"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_027","doi-asserted-by":"crossref","unstructured":"Erfani, H, Fox, KA, Clark, SL, Rac, M, Rocky Hui, SK, Rezaei, A, et al.. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol 2019;221:337.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2019.05.035.","DOI":"10.1016\/j.ajog.2019.05.035"},{"key":"2023040100552174320_j_jpm-2021-0263_ref_028","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Gronbeck, L, Bunce, C, Langhoff-Roos, J, Collins, SL. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open 2019;9:e031193. https:\/\/doi.org\/10.1136\/bmjopen-2019-031193.","DOI":"10.1136\/bmjopen-2019-031193"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0263\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0263\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T17:11:11Z","timestamp":1680369071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2021-0263\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,16]]},"published-print":{"date-parts":[[2022,3,28]]}},"alternative-id":["10.1515\/jpm-2021-0263"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2021-0263","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]}}}